MaxLinear, Inc. (MXL)
87.28
-1.71
(-1.92%)
USD |
NASDAQ |
Oct 13, 09:45
MaxLinear Research and Development Expense (Annual) : 208.60M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 208.60M |
| December 31, 2024 | 225.19M |
| December 31, 2023 | 269.50M |
| December 31, 2022 | 296.44M |
| December 31, 2021 | 278.44M |
| December 31, 2020 | 179.99M |
| December 31, 2019 | 98.30M |
| December 31, 2018 | 119.90M |
| December 31, 2017 | 111.73M |
| December 31, 2016 | 97.74M |
| Date | Value |
|---|---|
| December 31, 2015 | 85.40M |
| December 31, 2014 | 56.62M |
| December 31, 2013 | 53.13M |
| December 31, 2012 | 46.39M |
| December 31, 2011 | 40.16M |
| December 31, 2010 | 27.72M |
| December 31, 2009 | 19.79M |
| December 31, 2008 | 14.31M |
| December 31, 2007 | 9.924M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Marvell Technology, Inc. | 2.075B |
| Broadcom Inc. | 10.98B |
| Aehr Test Systems | 12.63M |
| Advanced Micro Devices, Inc. | 8.091B |
| Intel Corp. | 13.77B |